Keeping Track: NME Approvals For Evenity And Balversa; Non-NME Approvals For Dovato And Keytruda; But An RTF For Fintepla

 
• By Michael Cipriano and Bridget Silverman
Keeping Track Feature image

More from Product Reviews

More from Pink Sheet